Neudle.com: DAT

Differential
(Click to cross reference)

abiotrophy

abstract reasoning

acalculia

acetylcholine

acetylcholine in CNS

acetylcholine receptor

acetylcholinesterase

acetyl-L-carnitine

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome, older adults

activities of daily living

activities of daily living scale

aducanumab

advance directives

advances in neurology

adverse drug reaction

age associated memory impairment

alcohol, neurologic complications with

Alzheimer's disease associated protein

Alzheimer's disease, age of onset

Alzheimer's disease, behavioral symptoms

Alzheimer's disease, conjugal

Alzheimer's disease, diagnosis of

Alzheimer's disease, driving with

Alzheimer's disease, early onset

Alzheimer's disease, early symptoms

Alzheimer's disease, familial

Alzheimer's disease, familial, late onset

Alzheimer's disease, heterogeneity of

Alzheimer's disease, incidence

Alzheimer's disease, misdiagnosis

Alzheimer's disease, noncognitive symptoms

Alzheimer's disease, pathogenesis

Alzheimer's disease, patient awareness of

Alzheimer's disease, preclinical

Alzheimer's disease, prognosis of

Alzheimer's disease, rapidly progressive

Alzheimer's disease, rate of clinical decline

Alzheimer's disease, risk factors in

Alzheimer's disease, staging

Alzheimer's disease, telling patient diagnosis of

Alzheimer's disease, treating associated medical problems in

Alzheimer's disease, treatment of

Alzheimer's disease, vaccine

Alzheimer's disease, visual variant

amnesia

amygdala

amyloid

amyloid angiopathy, cerebral

amyloid beta protein

amyloid beta protein antibodies

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

anatomy of

aneuploidy

aneurysm, intracranial, familial

angiotensin II receptor blocker

anticholinergic drugs

anticholinesterase

anticoagulant, treatment

aphasia, logopenic, progressive

aphasia, progressive

aphasia, progressive, primary

aphasia, transcortical

aphasia, transcortical-sensory

apolipoprotein E

apolipoprotein E, false positive

apoliprotein E, plasma level

apraxia, constructional

autonomic dysfunction

Balint's syndrome

basilar artery migraine

behavior

behavior modification

behavior, combative

behavioral disorder

benign essential tremor

benign senescent forgetfulness

benzodiazepine

beta adrenergic blocker

brain transplantation

cardiac arrest and resuscitation

caregiver

carotid artery stenosis

CAT scan, emission, abnormal

CAT scan, indications for

CAT scan, normal ventricular size with aging

cell fusion test

central nervous system, infection of

cerebellar plaques, amyloid

cerebral blood flow

cerebral cortical atrophy

cerebral death

cerebral dominance

cerebral edema

cerebral edema, vasogenic

cerebral glucose metabolism

cerebral hemisphere left-right asymmetry

cerebral infarction

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, enzymes in

cerebrospinal fluid, hydroxyindoleacetic acid, 5(5-HIAA)

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, serotonin

cerebrovascular accident

cerebrovascular accident, multiple

cerebrovascular accident, recurrent

cerebrovascular accident, silent

cerebrovascular disease

chelation therapy

choline acetyltransferase

choline chloride

cholinergic drug

chorea

chromosomal abnormality

cisternogram, radionuclide

citalopram

claustrophobia

clindamycin

Clinical Pathologic Conference(C.P.C.)

color vision, impaired

color vision, impaired, cerebral

comorbidities

competency

complications

comprehension, impaired

conflict of interest

confusion

congenital malformation

congenital malformation, non CNS

contraindications

controversies in neurology

corpus callosum

corpus callosum, atrophy of

corpus callosum, neoplasm of

cortical-basal ganglionic degeneration

corticotropin-releasing factor

degenerative diseases of CNS

delusion

dementia

dementia, advanced

dementia, cerebrovascular disease causing

dementia, clinical diagnosis

dementia, diagnostic classification

dementia, diagnostic evaluation of

dementia, differential diagnosis of

dementia, driving with

dementia, early detection

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, incidence

dementia, mixed

dementia, posttraumatic

dementia, preexisting in stroke patient

dementia, presenile

dementia, prevalence of

dementia, prevention of

dementia, rapidly progressive

dementia, reversible

dementia, screening for

dementia, transmissible

dementia, treatment of

dementia, unknown etiology

denial of illness

deprenyl

depression

depth perception, impaired

differential diagnosis

dihydroepiandosterone

dimebon

disability rating scale, neurological

disability, neurological

disease modifying agents

dopamine beta hydroxylase

drug induced neurologic disorders

dysexecutive syndrome

dyskinesia, buccal lingual facial

dystonia, drug induced

dystonic reaction, acute

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, focal delta activity

electroencephalogram, periodic complexes

electroencephalogram, spike activity

electromagnetic fields

electron microscopy

electronic monitoring

employment

encephalitis, viral

encephalopathy, anoxic

endocarditis, native-valve

enkephalins

enzyme inhibition

enzyme, defect

epidemiology of neurology

ethics in neurology

evidence-based research

evoked potentials

excitotoxin

executive dysfunction

exercise

expert witness, medical

fibrinolytic agents, utilization

fish

Fisher C.M.

florbetapir

football neurologic injuries

fracture, long bone

Friedreich's ataxia

frontal lobe, anatomy and physiology

frontal lobe, behavior with disease of

frontal lobe, lesion of

frontal lobe, pathologic signs of

gait disorder

galantamine

gantenerumab

gastrostomy, percutaneous endoscopic

gaze palsy

gaze palsy, horizontal

genetic neurologic disorders

genetic screening

genetic testing

Gerstmann syndrome

Gilles de la Tourette syndrome

glioblastoma multiforme(astrocytoma Gr.III)

glioma

glutamic acid

GPS tracking

granulovacuolar degeneration

grasping

gray matter

hallucination

hallucination, auditory

hallucination, visual

haloperidol

handedness

head injury

head injury, hydrocephalus following

hemianopia, homonymous

hemianopia, isolated homonymous

hemiparesis

hemorrhagic diathesis

hemosiderosis of CNS, superficial

hemosiderosis, subarachnoid

hepatitis

heralding manifestation

herbs

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

histamine-2 receptor blockers

histochemistry

HMGcoA reductase inhibitors

hydrocephalus, normal pressure

hyperpyrexia, CNS disorder causing

hyperreflexia

hypertension

hypertension, cerebrovascular disease with

hypertropia

hyposmia

hypotension, systemic

hypoxia

hypoxic encephalopathy

iatrogenic neurologic disorders

imbalance, postural

immunization, neurologic complications with

immunoperoxidase staining

inappropriate behavior

inclusion bodies

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, intracytopasmic

inclusion bodies, location of

interobserver agreement

intracerebral hemorrhage

intracerebral hemorrhage, small

intranasal medication

Jakob-Creutzfeldt disease

judgement, impaired

Kluver-Bucy syndrome

laboratory values, normal

lacunar infarction

lacunar state

L-dopa

L-dopa, drug interactions with and side effects of

lecanemab

lecithin

left-right orientation

leukoencephalitis, acute necrotizing hemorrhagic

Lewy body

Lewy body disease, diffuse

life expectancy

life support, withdrawal of

lifestyle

limbic system

limbic-predominant age-related TDP-43 encephalopathy

liver function enzymes

lobar atrophy

locus ceruleus, lesion of

logopenia

lymphoma involving CNS

machine learning

managed care

manganese intoxication

manic-depressive

marital status

medical-legal aspects of neurology

medication withdrawal

memantine

memory

memory enhancement

Memory Impairment Screen

memory, defect of recent

memory, disorder, treatment of

memory, evaluation of

memory, impairment of

memory, impairment of, isolated

memory, impairment of, subjective

memory, recent

meningoencephalitis

menopause

mental status, evaluation of

metrifonate

microhemorrhage, intracerebral

microtubule

mild cognitive impairment

mild cognitive impairment converting to Alzheimer's disease

mimics

Mini Mental Status Examination

misdiagnosis

misdirection

misidentification

mitochondrial disease

molecular genetics

mongolism

monoamine oxidase inhibitors

monoclonal antibodies

movement disorder, drug induced

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, false negative

MRI, field strength, high

MRI, voxel-based morphometry

MRS

multiple sclerosis

multiple sclerosis, diagnosis of

multiple system atrophy

murder

muscarinic agonist

muscular dystrophy

muscular dystrophy, Duchenne

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve growth factor

neurofibrillary degeneration

neurofibromatosis 1

neurofibromatosis 2

neuroleptic

neuroleptic, atypical

neurologic complications of, systemic disease

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic evaluation

neurologic examination

neurologic history

neurologic signs

neurologic symptoms

neuronal degeneration

neuronal loss

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, amyloid

neuroprotective agents

non-dominant hemisphere

nonsteroidal anti-inflammatory drug

nucleus basalis of Meynert

nursing home

nylidrin

obsessive-compulsive disorder

occupational neurologic disorders

olanzapine

old age, driving and

old age, neurology of

olfactory bulb

optic nerve, lesion of

parietal lobe, atrophy

parietal lobe, lesion of

parietal lobe, syndromes of

Parkinson disease

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, drug induced

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, heterogeneity of

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

PAS positive material in the brain

pathologic reflex

pathology

patient information and support

peptides, brain

perihippocampal fissure

perimetry

perimetry, computerized

persistent vegetative state

persistent vegetative state, children

persistent vegetative state, etiology of

Pittsburgh Compound B

placebo

pleocytosis of cerebrospinal fluid

pneumoencephalogram(PEG)

pneumonia

polyneuropathy

posterior cerebral artery occlusion

posterior cortical atrophy

prevention of neurologic disorders

progesterone

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive supranuclear palsy

pseudobulbar palsy

pseudodementia

psychiatric disorder

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

psychosis

psychotic behavior

pupil

pupil, abnormality in neurologic disorders

rapidly progressing neurologic illness

reading

reading disorder, acquired

reading problem, causes of

recombinant DNA

recurrent

reduplicative paramnesia

release phenomena

repetitive questioning

rheumatoid arthritis, neurologic complications of

rhinorrhea, CSF

rigidity

risk factors

risk factors, modification

risk-benefit assessment

seizure, diagnosis of

seizure, psychomotor-temporal lobe

seizure, risk factors for

seizure, surgical treatment of

selective serotonin reuptake inhibitors

serum alanine aminotransferase

sexual behavior, disorder of

shadowing

shared decision making

sildenafil

simultanagnosia

simvastatin

single photon emission computed tomography

single photon emission computed tomography, false negative

skin, lesions in neurologic disorders

sleep

sleep pathology and physiology

smell

Smell Identification Test

snout reflex

sodium-glucoe cotransporter-2 inhibitors

speech disorder

speech, loss of

spinal cord, injury of

spinal muscular atrophy

spinocerebellar ataxia

spinocerebellar ataxia type 1

spongy degeneration of brain

staining reactions in neuropathology

statin therapy

stem cell transplantation

stereotyped behavior

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

stooped posture

stress, emotional

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

temporal lobe, atrophy

temporal lobe, lesion

temporal lobe, lesion, bilateral

tetrahydroaminoacridine

tissue plasminogen activator, intravenous

TRAILBLAZER-ALZ trial

trauma

trazodone

treatment of neurologic disorder

treatment, non-pharmacologic

TREM2 variants

tremor

trinucleotide repeats

vaccination, neurologic complications with

vasodilating agents in treatment of cerebrovascular disease

velnacrine

ventricular enlargement

vincamine

vinpocetine

viral infection, CNS

visual acuity, decreased

visual evoked response

visual field defect

visual field testing

visual fields

visual fields, constricted

visuospatial disturbance

vitamin E

vitamin supplementation

vitamin therapy

walking, difficulty with

white matter disease, periventricular

whites

word-finding difficulty

workup

writing

Showing articles 550 to 600 of 665 << Previous Next >>

Genetic Linkage in Neurologic Diseases
Editorial, NEJM 316:1018-10201987., Martin,J.B., 1987

Cognitive & Neurologic Findings in Demented Patients with Diffuse White Matter Lucencies on CT Scan (Leuko-Araiosis)
Arch Neurol 44:36-39, Steingard,A.,et al, 1987

A Controlled Study of Survival with Dementia
Arch Neurol 44:1122-1126, Martin,D.C.,et al, 1987

Early-Onset Alzheimer's Disease:Clinical Predictors of Institutionalization & Death
Neurol 37:980-984, Heyman,A.,et al, 1987

Alzheimer's Disease
Down's Syndrome, & Chromosome 21, Editorial, Lancet 1:1011-1012., , 1987

Effects of Oral Physostigmine in Alzheimer's Disease
Ann Neurol 22:306-310, Stern,Y.,et al, 1987

Cortical Biopsy Results in Alzheimer's Disease:Correlation with Cognitive Deficits
Neurol 37:1201-1204, Martin,E.M.,et al, 1987

Predictors of Disease Course in Patients with Probable Alzheimer's Disease
Neurol 37:1649-1653, Stern,Y.,et al, 1987

Risk Factors for Alzheimer's Disease:A Case-Control Study
Neurol 37:1630-1633, Shalat,S.T.,et al, 1987

The Neurologic Examination in Patients with Probable Alzheimer's Disease
Arch Neurol 44:929-932, Huff,F.J.,et al, 1987

Olfactory Deficits as a Neurologic Sign in Dementia of the Alzheimer Type
Arch Neurol 44:1030-1032, Rezek,D.L., 1987

Neuropathologic & Clinical Features of Parkinson's Disease in Alzheimer's Disease Patients
Neurol 37:754-760, Ditter,S.M.&Mirra,S.S., 1987

Comparison of Magnetic Resonance & Roentgen Ray Computed Tomography in Dementia
Arch Neurol 44:1075-1080, Johnson,K.A.,et al, 1987

Periventricular White Matter Lucencies in Senile Dementia of the Alzheimer Type & in Normal Aging
Neurol 37:1365-1368, Rezek,D.L.,et al, 1987

Alzheimer's Disease & Other Dementing Illnesses in a Defined US Population:Incidence Rates & Clx Features
Ann Neurol 22:724-729, Schoenberg,B.S.,et al, 1987

The Role of Glutamate in Neurotransmission & in Neurologic Disease
Arch Neurol 43:1058-1063, Greenamyre,J.T., 1986

Alzheimer's Disease, Parkinson's Disease, & Motoneurone Disease:Abiotropic Interaction Between Ageing & Environment
Lancet 2:1067-1068, Calne,D.B.,et al, 1986

Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
NEJM 315:1241-1245, Summers,W.K.,et al, 1986

Alzheimer's Disease
Am J Med 81:91-96, Kwentus,J.A.,et al, 1986

Seizures & Myoclonus in Patients with Alzheimer's Disease
Neurol 36:1226-1230, Hauser,W.A.,et al, 1986

Optic-Nerve Degeneration in Alzheimer's Disease
NEJM 315:485-487, Hinton,D.R.,et al, 1986

Defective Brain Microtubule Assembly in Alzheimer's Disease
Lancet 2:421-426, Iqbal,K.,et al, 1986

Dementia
Council on Scientific Affairs, JAMA 256:2234-22381986., , 1986

Hospice Approach to the Treatment of Patients with Advanced Dementia of the Alzheimer Type
JAMA 256:2210-2213, 2244-22451986., Volicer,L.,et al, 1986

The Prevalence of Lingual-Facial-Buccal Dynkinesias in the Elderly
Neurol 36:1350-1351, D'Alessandro,R.,et al, 1986

Neuropeptides in Neurological Disease
Ann Neurol 20:547-565, Beal,M.F.&Martin,J.B., 1986

Comparison of PET, MRI, & CT with Pathology in a Proven Case of Alzheimer's Disease
Neurol 36:1569-1574, McGeer,P.L.,et al, 1986

Positron Emission Tomography in Dementia of the Alzheimer Type
Arch Int Med 146:2045-2049, Berg,G.,et al, 1986

Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986

Epidemiology of Clinically Diagnosed Alzheimer's Disease
Ann Neurol 19:415-424, Rocca,W.A.,et al, 1986

Serial Visual Evoked Potential Recordings in Alzheimer's Disease
BMJ 293:9-10, Orwin,A.,et al, 1986

Parkinson's Disease in Patients with Alzheimer's Disease
Arch Neurol 43:662-664, Leverenz,J.&Sumi,S.M., 1986

Positron Emission Tomography in Alzheimer's Disease
Neurol 36:879-887, Duara,R.,et al, 1986

Muscarinic Acetylcholine Receptors in Alzheimer's Disease
JAMA 254:3063-3066, Holman,B.L.,et al, 1985

Corticotropin-Releasing Factor-Like Immunoreactivity in Senile Dementia of the Alzheimer Type
JAMA 254:3067-3069, 30851985., Bissette,G.,et al, 1985

A New Definition of Alzheimer's Disease:A Hippocampal Dementia
Lancet 1:14-16, Ball,M.J.,et al, 1985

Head Injury as a Risk Factor for Alzheimer's Disease
Neurol 35:264-267, Mortimer,J.A.,et al, 1985

Serotoninergic System in Dementia of the Alzheimer Type
Arch Neurol 42:1158-1161, Volicer,L.,et al, 1985

Diagnosis of Alzheimer's Disease
Arch Neurol 42:1097-1105, MaKhachaturian,Z.S., 1985

Clinical Subtypes of Dementia of the Alzheimer Type
Neurol 35:1544-1550, Chui,H.C.,et al, 1985

The Nucleus Basalis of Meynert in Neurological Disease:A Quantitative Morphological Study
Ann Neurol 17:163-170, Rogers,J.D.,et al, 1985

Neurochemical Studies of Early Onset Alzheimer's Disease, Possible Influence on Treatment
NEJM 313:7-11, Francis,P.T.,et al, 1985

Survival in Alzheimer's Disease & Vascular Dementias
Neurol 35:834-840, Barclay,L.L.,et al, 1985

Heterogeneity in Dementia of the Alzheimer Type:Evidence of Subgroups
Neurol 35:453-461, Mayeux,R.,et al, 1985

Rational Drug Treatment of Dementia? Editorial
BMJ 290:1845-1846, , 1985

Neuronal Pathology in the Nucleus Basalis & Associated Cell Groups in Senile Dementia of the Alzheimer's Type
Neurol 35:1089-1095, Saper,C.B.,et al, 1985

Aphasia in Dementia of the Alzheimer Type
Neurol 35:394-397, Cummings,J.L.,et al, 1985

Atypical Alzheimer's Disease with Spastic Paresis & Ataxia
Ann Neurol 17:297-300, Aikawa,H.,et al, 1985

Cerebrospinal Fluid Acetylcholinesterase Activity in Senile Dementia of the Alzheimer Type
Ann Neurol 17:46-48, Tune,L.,et al, 1985

Olfactory Dysfunction in Alzheimer's Disease & Parkinson's Disease
Am J Psychiatry 142:781-782, Serby,M.,et al, 1985

Showing articles 550 to 600 of 665 << Previous Next >>